Within a full week, all 50 claims were following these guidelines. The people becoming monitored got their own temps a day twice, and reported their wellness status to a public health official at least one time daily. Those deemed at risky for Ebola disease reported their health status twice daily, and had the official come by to check on them in person at least one time a full day. From November to March, 10,344 people were each monitored for 21 days for symptoms of Ebola, according to the new record. During the average week within that period, about 20 of the people being monitored reported having symptoms that might have been due to Ebola, with the highest amount being reported in December.Investors will get current financial disclosures and Real-Time Level 2 quotations for the ongoing business on We welcome Abattis to the OTCQX market place, said R. Cromwell Coulson, CEO and President of OTC Marketplaces Group. Abattis joins a growing group of Canadian exchange-listed businesses that have selected to trade on the OTCQX marketplace to provide its investors with transparent trading and practical usage of its news and financials. We wish the company continued success. Related StoriesRebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infectionAmgen's IMLYGIC receives positive opinion from CHMP for treatment of melanomaUniversity of Leicester awarded BBSRC grant to explore 3 key areas that effect human wellness Abattis Bioceuticals is dedicated to providing a high level of transparency to shareholders, said Abattis Bioceuticals Corp.